Loading
SI-BONE, Inc. is a medical technology company that develops and markets specialized implantable solutions for musculoskeletal conditions affecting the sacropelvic region. These devices are utilized across the United States and internationally. Its flagship product, iFuse, is a minimally invasive surgical implant system designed to address a range of indications, including sacroiliac joint dysfunction and degeneration, adult spinal deformities, and traumatic fractures of the pelvic ring. Beyond iFuse, the company offers advanced iterations like iFuse-3D. This titanium implant retains the distinctive triangular cross-section of the original iFuse but incorporates a proprietary 3D-printed porous surface and a fenestrated design. Another offering is iFuse-TORQ, a series of 3D-printed threaded implants. These are specifically engineered for treating pelvic fractures and facilitating minimally invasive sacroiliac joint fusion procedures. SI-BONE distributes its products primarily through a dedicated direct sales force, complemented by a network of independent distributors. Established in 2008, the company maintains its corporate headquarters in Santa Clara, California.
Previous close
$19.37
+$0.51 · +2.70%
After-hours
$19.37
$0.00 · 0.00%
Oct 9, 7:30 PM ET
Regular session · ET · Market data may be delayed.
SI-BONE, Inc. is a medical technology company that develops and markets specialized implantable solutions for musculoskeletal conditions affecting the sacropelvic region. These devices are utilized across the United States and internationally. Its flagship product, iFuse, is a minimally invasive surgical implant system designed to address a range of indications, including sacroiliac joint dysfunction and degeneration, adult spinal deformities, and traumatic fractures of the pelvic ring. Beyond iFuse, the company offers advanced iterations like iFuse-3D. This titanium implant retains the distinctive triangular cross-section of the original iFuse but incorporates a proprietary 3D-printed porous surface and a fenestrated design. Another offering is iFuse-TORQ, a series of 3D-printed threaded implants. These are specifically engineered for treating pelvic fractures and facilitating minimally invasive sacroiliac joint fusion procedures. SI-BONE distributes its products primarily through a dedicated direct sales force, complemented by a network of independent distributors. Established in 2008, the company maintains its corporate headquarters in Santa Clara, California.
Day range
Current $19.37
52-week range
Current $19.37
Regular session · ET · Market data may be delayed.
GoAI Score
Buy
Valuation
99
Deep Value
Sentiment
49
Mixed
Risk
38
Moderate Risk
Momentum
58
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
SI-BONE, Inc. is a medical technology company that develops and markets specialized implantable solutions for musculoskeletal conditions affecting the sacropelvic region. These devices are utilized across the United States and internationally. Its flagship product, iFuse, is a minimally invasive surgical implant system designed to address a range of indications, including sacroiliac joint dysfunction and degeneration, adult spinal deformities, and traumatic fractures of the pelvic ring. Beyond iFuse, the company offers advanced iterations like iFuse-3D. This titanium implant retains the distinctive triangular cross-section of the original iFuse but incorporates a proprietary 3D-printed porous surface and a fenestrated design. Another offering is iFuse-TORQ, a series of 3D-printed threaded implants. These are specifically engineered for treating pelvic fractures and facilitating minimally invasive sacroiliac joint fusion procedures. SI-BONE distributes its products primarily through a dedicated direct sales force, complemented by a network of independent distributors. Established in 2008, the company maintains its corporate headquarters in Santa Clara, California.
Day range
Current $19.37
52-week range
Current $19.37
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 200.93M USD | 167.18M USD | 138.89M USD | 106.41M USD | 90.15M USD |
| Cost of goods sold | 41.05M USD | 35.06M USD | 29.47M USD | 15.71M USD | 10.43M USD |
| Gross profit | 159.88M USD | 132.12M USD | 109.42M USD | 90.7M USD | 79.72M USD |
| Research and development | 17.45M USD | 16.56M USD | 15.03M USD | 13.63M USD | 12.44M USD |
| Selling, general, and administrative | 164.76M USD | 150.81M USD | 141.32M USD | 136.69M USD | 118.95M USD |
| Operating expenses | 182.21M USD | 167.37M USD | 156.35M USD | 150.31M USD | 131.39M USD |
| Interest income | 6.07M USD | 7.85M USD | 6.92M USD | 1.3M USD | 186K USD |
| Interest expense | 5.28M USD | 3.44M USD | 3.46M USD | 2.82M USD | 5.37M USD |
| Depreciation and amortization | 2.72M USD | 4.38M USD | 5.43M USD | 3.45M USD | 2.09M USD |
| Operating income | −22.33M USD | −35.25M USD | −46.93M USD | −59.61M USD | −51.67M USD |
| Net income | −18.91M USD | −30.91M USD | −43.34M USD | −61.26M USD | −56.57M USD |
Company facts updated Oct 10, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI25.43M0.00%2.3T USD0.03%$381.94+0.63%
iShares Russell 2000 ETFIWM21.8M0.03%78.27B USD0.19%$278.94+0.49%
Vanguard Extended Market ETFVXF8.81M0.01%95.4B USD0.05%$235+0.80%
iShares Russell 2000 Growth ETFIWO7.6M0.06%13.97B USD0.24%$356.78+0.94%
Dimensional - US Small Cap ETFDFAS5.28M0.02%33.87B USD0.31%$78.35+0.32%
Vanguard Russell 2000 ETFVTWO4.81M0.03%18B USD0.06%$112.66+0.50%
Schwab U.S. Small-Cap ETFSCHA4.54M0.02%21.73B USD0.03%$32.79+0.40%
iShares U.S. Medical Devices ETFIHI4.18M0.12%3.55B USD0.37%$51.74+1.25%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFiShares Russell 2000 Growth ETFIWODimensional - US Small Cap ETFDFASVanguard Russell 2000 ETFVTWOSchwab U.S. Small-Cap ETFSCHAiShares U.S. Medical Devices ETFIHIAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
